Literature DB >> 12434547

Efficacy and tolerability of acemetacin, a non-steroidal anti-inflammatory drug, in Mexican patients: result of the ETAPAM Study.

Gerardo Bori Segura1, Arturo Torres y Gutierrez Rubio, Luis Eduardo Herrera Gómez, Jorge Olguín Uribe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12434547

Source DB:  PubMed          Journal:  Proc West Pharmacol Soc        ISSN： 0083-8969


× No keyword cloud information.
  4 in total

1.  Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases.

Authors:  Christian Dejaco; Christina Duftner; Michael Schirmer
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

2.  Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin.

Authors:  A E Chávez-Piña; W McKnight; M Dicay; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

3.  Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety.

Authors:  A E Chávez-Piña; L Vong; W McKnight; M Dicay; R C O Zanardo; M I Ortiz; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

4.  Gene expression profiling analysis of keloids with and without hydrocortisone treatment.

Authors:  Hongyi Wang; Liangliang Quan; Jiulong Liang; Jie Shi; Tao Qiu; Ye Zhang; Yang Wang; Qiang Hui; Yu Zhang; Kai Tao
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.